Caris Life Sciences (CAI) Net Margin (2024 - 2026)

Caris Life Sciences (CAI) posted quarterly Net Margin of 0.24% for Q1 2026, up 10483.0% year-over-year from N/an in Q1 2025, and down 100.84% quarter-over-quarter from 27.98% in Q4 2025.

Caris Life Sciences (CAI) Net Margin (2024 - 2026) Analysis & Trends

Caris Life Sciences' Net Margin history runs 3 years deep, the most recent figure standing at 0.24% for Q1 2026.

  • In Q1 2026, Net Margin rose 10483.0% year-over-year to 0.24%; the TTM figure through Mar 2026 stood at 45.35% (up 3668.0% YoY), while the FY2025 annual figure was 66.25%, up 2550.0% from the prior year.
  • Net Margin for Q1 2026 stood at 0.24%, down from 27.98% in the prior quarter.
  • The five-year high for Net Margin was 27.98% in Q4 2025, with the low at 285.12% in Q2 2025.
  • The 3-year median for Net Margin is 68.71% (2024), against an average of 72.44%.
  • The sharpest annual moves came in 2025 and 2026: Net Margin sank 19538 bps in 2025, then surged 10483 bps in 2026.
  • Caris Life Sciences' Net Margin stood at 47.68% in 2024, then surged by 159 bps to 27.98% in 2025, then slumped by 101 bps to 0.24% in 2026.
  • Business Quant data shows CAI's Net Margin at 0.24% in Q1 2026, 27.98% in Q4 2025, and 11.22% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 32.99%
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 30.23%
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 30.33%
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 13.90%
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 30.98%
7 Royalty Pharma 33.72 Bn 35.84 Bn - 12.09%
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 12.74%
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -3.12%
10 Caris Life Sciences 6.16 Bn 5.37 Bn 182.38 Mn -0.24%

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.24%
Mar 31, 2026 -0.24%
Dec 31, 2025 27.98%
Sep 30, 2025 11.22%
Jun 30, 2025 -285.12%
Mar 31, 2025 -105.07%
Dec 31, 2024 -47.68%
Sep 30, 2024 -90.92%
Jun 30, 2024 -89.74%